Patient-Centric Approaches for Phase I Combination Trials Come on Stage

por Hernando-Calvo, Alberto, Garralda, Elena
Publicado 2023

Unmasking New Promises: Expanding the Antigen Landscape For Antibody–Drug Conjugates

por Oberoi, Honey K., Garralda, Elena
Publicado 2021

Towards evidence-based response criteria for cancer immunotherapy

por Garralda, Elena, Laurie, Scott A., Seymour, Lesley, de Vries, Elisabeth G. E.
Publicado 2023

New clinical trial designs in the era of precision medicine

por Garralda, Elena, Dienstmann, Rodrigo, Piris‐Giménez, Alejandro, Braña, Irene, Rodon, Jordi, Tabernero, Josep
Publicado 2019

Public and patient involvement: a survey on knowledge, experience and opinions among researchers within a precision oncology European project

por Mosconi, Paola, Colombo, Cinzia, Paletta, Pasquale, Gangeri, Laura, Pellegrini, Chiara, Garralda, Elena, Miceli, Rosalba, Brunelli, Cinzia
Publicado 2023

Hyperprogression and Immunotherapy: Fact, Fiction, or Alternative Fact?

por Adashek, Jacob J., Subbiah, Ishwaria M., Matos, Ignacio, Garralda, Elena, Menta, Arjun K., Ganeshan, Dhakshina Moorthy, Subbiah, Vivek
Publicado 2020

HER2/neu testing for anti-HER2-based therapies in patients with unresectable and/or metastatic gastric cancer

por Gómez-Martin, Carlos, Garralda, Elena, Echarri, M José, Ballesteros, Anabel, Arcediano, Alberto, Rodríguez-Peralto, José Luis, Hidalgo, Manuel, López-Ríos, Fernando
Publicado 2012

Phase 1 first-in-human dose-escalation study of ANV419 in patients with relapsed/refractory advanced solid tumors

por Joerger, Markus, Calvo, Emiliano, Laubli, Heinz, Lopez, Juanita, Alonso, Guzmán, Corral de la Fuente, Elena, Hess, Dagmar, König, David, Sanchez Perez, Vicky, Bucher, Christoph, Jethwa, Sangeeta, Garralda, Elena
Publicado 2023

Gender-related challenges facing oncologists: the results of the ESMO Women for Oncology Committee survey

por Banerjee, Susana, Dafni, Urania, Allen, Tamara, Arnold, Dirk, Curigliano, Giuseppe, Garralda, Elena, Garassino, Marina Chiara, Haanen, John, Hofstädter-Thalmann, Eva, Robert, Caroline, Sessa, Cristiana, Tsourti, Zoi, Zygoura, Panagiota, Peters, Solange
Publicado 2018

Report on the status of women occupying leadership roles in oncology

por Hofstädter-Thalmann, Eva, Dafni, Urania, Allen, Tamara, Arnold, Dirk, Banerjee, Susana, Curigliano, Giuseppe, Garralda, Elena, Garassino, Marina Chiara, Haanen, John, Robert, Caroline, Sessa, Cristiana, Tsourti, Zoi, Zygoura, Panagiota, Peters, Solange
Publicado 2018

A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer

por Jones, Robert, Plummer, Ruth, Moreno, Victor, Carter, Louise, Roda, Desamparados, Garralda, Elena, Kristeleit, Rebecca, Sarker, Debashis, Arkenau, Tobias, Roxburgh, Patricia, Walter, Harriet S., Blagden, Sarah, Anthoney, Alan, Klencke, Barbara J., Kowalski, Mark M., Banerji, Udai
Publicado 2023

A Phase Ib/II Study of WNT974 + Encorafenib + Cetuximab in Patients With BRAF (V600E)-Mutant KRAS Wild-Type Metastatic Colorectal Cancer

por Tabernero, Josep, Van Cutsem, Eric, Garralda, Elena, Tai, David, De Braud, Filippo, Geva, Ravit, van Bussel, Mark T J, Fiorella Dotti, Katia, Elez, Elena, de Miguel, María J, Litwiler, Kevin, Murphy, Danielle, Edwards, Michelle, Morris, Van Karlyle
Publicado 2023

Clinical validation of prospective liquid biopsy monitoring in patients with wild-type RAS metastatic colorectal cancer treated with FOLFIRI-cetuximab

por Toledo, Rodrigo A., Cubillo, Antonio, Vega, Estela, Garralda, Elena, Alvarez, Rafael, de la Varga, Lisardo U., Pascual, Jesús R., Sánchez, Gema, Sarno, Francesca, Prieto, Susana H., Perea, Sofía, Lopéz-Casas, Pedro P., López-Ríos, Fernando, Hidalgo, Manuel
Publicado 2016

Manufacturing‐dependent change in biological activity of the TLR4 agonist GSK1795091 and implications for lipid A analog development

por Steeghs, Neeltje, Hansen, Aaron R., Hanna, Glenn J., Garralda, Elena, Park, Haeseong, Strauss, James, Adam, Michael, Campbell, Gossett, Carver, Jennifer, Easton, Rachael, Mays, Katherine, Skrdla, Peter, Struemper, Herbert, Washburn, Michael L., Matheny, Christopher, Piha‐Paul, Sarina A.
Publicado 2022

Cellular Senescence Is Immunogenic and Promotes Antitumor Immunity

por Marin, Ines, Boix, Olga, Garcia-Garijo, Andrea, Sirois, Isabelle, Caballe, Adrià, Zarzuela, Eduardo, Ruano, Irene, Attolini, Camille Stephan-Otto, Prats, Neus, López-Domínguez, José A, Kovatcheva, Marta, Garralda, Elena, Muñoz, Javier, Caron, Etienne, Abad, María, Gros, Alena, Pietrocola, Federico, Serrano, Manuel
Publicado 2023

Pan-cancer efficacy of pralsetinib in patients with RET fusion–positive solid tumors from the phase 1/2 ARROW trial

por Subbiah, Vivek, Cassier, Philippe A., Siena, Salvatore, Garralda, Elena, Paz-Ares, Luis, Garrido, Pilar, Nadal, Ernest, Vuky, Jacqueline, Lopes, Gilberto, Kalemkerian, Gregory P., Bowles, Daniel W., Seetharam, Mahesh, Chang, Jianhua, Zhang, Hui, Green, Jennifer, Zalutskaya, Alena, Schuler, Martin, Fan, Yun, Curigliano, Giuseppe
Publicado 2022

Exploring the Immunogenicity of Noncanonical HLA-I Tumor Ligands Identified through Proteogenomics

por Lozano-Rabella, Maria, Garcia-Garijo, Andrea, Palomero, Jara, Yuste-Estevanez, Anna, Erhard, Florian, Farriol-Duran, Roc, Martín-Liberal, Juan, Ochoa-de-Olza, Maria, Matos, Ignacio, Gartner, Jared J., Ghosh, Michael, Canals, Francesc, Vidal, August, Piulats, Josep Maria, Matías-Guiu, Xavier, Brana, Irene, Muñoz-Couselo, Eva, Garralda, Elena, Schlosser, Andreas, Gros, Alena
Publicado 2023

Genomically matched therapy in refractory colorectal cancer according to ESMO Scale for Clinical Actionability of Molecular Targets: experience of a comprehensive cancer centre net...

por Mulet Margalef, Núria, Castillo, Carmen, Mosteiro, Miguel, Pérez, Xavier, Aguilar, Susana, Ruíz‐Pace, Fiorella, Gil, Marta, Cuadra, Carmen, Ruffinelli, José Carlos, Martínez, Mercedes, Losa, Ferran, Soler, Gema, Teulé, Àlex, Castany, Roser, Gallego, Rosa, Ruíz, Andrea, Garralda, Elena, Élez, Elena, Vivancos, Ana, Tabernero, Josep, Salazar, Ramon, Dienstmann, Rodrigo, Santos Vivas, Cristina
Publicado 2023

Author Correction: Caring for patients with cancer in the COVID-19 era

por van de Haar, Joris, Hoes, Louisa R., Coles, Charlotte E., Seamon, Kenneth, Fröhling, Stefan, Jäger, Dirk, Valenza, Franco, de Braud, Filippo, De Petris, Luigi, Bergh, Jonas, Ernberg, Ingemar, Besse, Benjamin, Barlesi, Fabrice, Garralda, Elena, Piris-Giménez, Alejandro, Baumann, Michael, Apolone, Giovanni, Soria, Jean Charles, Tabernero, Josep, Caldas, Carlos, Voest, Emile E.
Publicado 2020

LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8(+) T cell tumor-infiltration impairing anti-PD1 therapy

por Pascual-García, Mónica, Bonfill-Teixidor, Ester, Planas-Rigol, Ester, Rubio-Perez, Carlota, Iurlaro, Raffaella, Arias, Alexandra, Cuartas, Isabel, Sala-Hojman, Ada, Escudero, Laura, Martínez-Ricarte, Francisco, Huber-Ruano, Isabel, Nuciforo, Paolo, Pedrosa, Leire, Marques, Carolina, Braña, Irene, Garralda, Elena, Vieito, María, Squatrito, Massimo, Pineda, Estela, Graus, Francesc, Espejo, Carmen, Sahuquillo, Juan, Tabernero, Josep, Seoane, Joan
Publicado 2019